Reducing Emergency Department Utilization With an After Visit Summary Nudge Toward Alternative Care Options

NCT ID: NCT05787548

Last Updated: 2024-02-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

239841 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-03

Study Completion Date

2023-12-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Decreasing utilization of the Emergency Department (ED) is a priority for the system. Often, ED visits can be avoided if patients contact Geisinger first to get appropriate direction for their concern or are otherwise better informed about reasons to visit the ED vs. urgent care or primary care facilities. The study team is working to reduce ED utilization by including additional information in adult outpatient After Visit Summaries (AVSs). The study will involve will involve A/B testing different AVS versions, including 1) a version that encourages patients to contact Geisinger via different contact methods, 2) a version that includes a map to the patient's closest ConvenientCare location and accompanying information about ConvenientCare, and 3) a version that includes a self-triage guide. A control group will receive the current standard AVS. Analysis results will be assessed to determine which version is most effective at reducing ED use.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Behavior, Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard practice

Patients in this arm will receive the current standard practice AVS.

Group Type NO_INTERVENTION

No interventions assigned to this group

Contact us first

Patients in this arm will receive the standard AVS, plus information on how to contact Geisinger if they need medical attention.

Group Type EXPERIMENTAL

Contact information

Intervention Type BEHAVIORAL

Information on how to contact Geisinger if the patient needs care

Contact us first + urgent care map

Patients in this arm will receive the standard AVS, plus information on how to contact Geisinger if they need medical attention, plus a map to their nearest Geisinger urgent care location and additional information about urgent care.

Group Type EXPERIMENTAL

Contact information

Intervention Type BEHAVIORAL

Information on how to contact Geisinger if the patient needs care

Urgent care map

Intervention Type BEHAVIORAL

A map of the patient's nearest Geisinger urgent care location, with information about urgent care

Contact us first + urgent care map + self-triage

Patients in this arm will receive the standard AVS, plus information on how to contact Geisinger if they need medical attention, plus a map to their nearest Geisinger urgent care location and additional information about urgent care. This arm will also receive a self-triage chart, with common reasons patients go to the ED and situations where seeking alternative care might be appropriate.

Group Type EXPERIMENTAL

Contact information

Intervention Type BEHAVIORAL

Information on how to contact Geisinger if the patient needs care

Urgent care map

Intervention Type BEHAVIORAL

A map of the patient's nearest Geisinger urgent care location, with information about urgent care

Self-triage chart

Intervention Type BEHAVIORAL

A chart demonstrating what to do in response to several common conditions where the patient might be compelled to visit the ED

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Contact information

Information on how to contact Geisinger if the patient needs care

Intervention Type BEHAVIORAL

Urgent care map

A map of the patient's nearest Geisinger urgent care location, with information about urgent care

Intervention Type BEHAVIORAL

Self-triage chart

A chart demonstrating what to do in response to several common conditions where the patient might be compelled to visit the ED

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18+
* Has a Geisinger Primary Care Physician assigned
* Completes an outpatient office visit or telemedicine appointment at Geisinger

Exclusion Criteria

* The AVS was not printed according to the EHR, and the patient does not have an active MyGeisinger patient portal account, so they do not have a way to view the AVS
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Geisinger Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amir Goren

Program Director, Behavioral Insights Team

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amir Goren, PhD

Role: PRINCIPAL_INVESTIGATOR

Geisinger Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Geisinger Clinic

Danville, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-0340

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Communication During Hospitalization About Resuscitation Trial
NCT02984124 ACTIVE_NOT_RECRUITING PHASE2/PHASE3
Decision Support AMPATH
NCT01235247 UNKNOWN NA